Glutathione CAS:70-18-8

Glutathione

Chemical Name:Glutathione
CAS.NO:70-18-8
Synonyms:Glutathione
L-Glutathione
L-Glutathione Reduced
L-γ-Glutamyl-L-cysteinylglycine
Reduced glutathione
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 754.5±60.0 °C at 760 mmHg
Melting Point 182-192ºC
Molecular Formula C10H17N3O6S
Molecular Weight 307.323
Flash Point 410.1±32.9 °C
Vapour Pressure 0.0±5.5 mmHg at 25°C
Index of Refraction 1.572
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:(1) Radiation sickness and radiation safety: radiation, radioactive substances or because of leukopenia caused by anticancer drugs and other symptoms can play a protective effect. 
(2) To protect the liver, detoxification, inactivation of hormones, and to promote bile acid metabolism and help absorb fat and fat-soluble vitamins digestive tract. 
(3) Anti-allergy, or inflammation caused by hypoxemia in patients with systemic or local, can reduce cell damage and promote repair. 
(4) To improve the course of certain diseases and symptoms as adjuvant drugs. Such as: hepatitis, hemolytic disease, and keratitis, cataract and retinal diseases, such as eye disease and improve vision. 
(5) Easy to speed up the metabolism of acids in the excretion of free radicals, which play a beauty skin care, anti-aging effect.



We are professional Glutathione manufacturer and Reduced glutathione supplier in China, We offer quality Glutathione you can fully trust, also we have India factory and producer of Reduced glutathione,Pls send inquiry of L-Glutathione CAS:70-18-8 to info@nbinno.com if you have any interests, thank you!


Related News: Health officials said it remained unclear where he had developed the disease.5-methyl-3H-1,3,4-thiadiazole-2-thione After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.3430-33-9 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.(2-bromo-4-fluorophenyl)methanol CAS:229027-89-8 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.